Platelet interleukin-1α drives cerebrovascular inflammation

Blood

Volumn 115, Issue 17, 2010, Pages 3632-3639

  Thornton, Peter ^a   McColl, Barry W ^a   Greenhalgh, Andrew ^a   Denes, Adam ^a   Allan, Stuart M ^a   Rothwell, Nancy J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; NEUTRALIZING ANTIBODY; VASCULAR CELL ADHESION MOLECULE 1; CXCL1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CELL; BRAIN INJURY; CELL MIGRATION; CEREBROVASCULAR DISEASE; CEREBROVASCULAR INFLAMMATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; ENDOTHELIUM CELL; LEUKOCYTE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THROMBOCYTE; WILD TYPE; ANIMAL; BIOSYNTHESIS; BRAIN ISCHEMIA; CELL MOTION; DRUG EFFECT; ENCEPHALITIS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; THROMBOCYTE ACTIVATION; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD PLATELETS; BRAIN ISCHEMIA; CELL MOVEMENT; CHEMOKINE CXCL1; ENCEPHALITIS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1ALPHA; MICE; MICE, KNOCKOUT; NEUTROPHIL INFILTRATION; NEUTROPHILS; PLATELET ACTIVATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 77951735539     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-11-252643     Document Type: Article

References (49)

1. del Zoppo GJ. Inflammation and the neurovascular unit in the setting of focal cerebral ischemia. Neuroscience. 2009;158(3):972-982.
2. Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron. 2008;57(2):178-201.
3. Fabene PF, Navarro MG, Martinello M, et al. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med. 2008;14(12):1377-1383.
4. Massberg S, Brand K, Gruner S, et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med. 2002;196(7):887-896.
5. Choudhri TF, Hoh BL, Zerwes HG, et al. Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation. J Clin Invest. 1998;102(7):1301-1310.
6. Ishikawa M, Cooper D, Arumugam TV, Zhang JH, Nanda A, Granger DN. Platelet-leukocyte-endothelial cell interactions after middle cerebral artery occlusion and reperfusion. J Cereb Blood Flow Metab. 2004;24(8):907-915. (Pubitemid 39045408)
7. Jafar JJ, Menoni R, Feinberg H, LeBreton G, Crowell RM. Selective platelet deposition during focal cerebral ischemia in cats. Stroke. 1989;20(5):664-667. (Pubitemid 19139098)
8. Kochanek PM, Dutka AJ, Kumaroo KK, Hallenbeck JM. Effects of prostacyclin, indomethacin, and heparin on cerebral blood flow and platelet adhesion after multifocal ischemia of canine brain. Stroke. 1988;19(6):693-699.
9. Littleton-Kearney MT, Hurn PD, Kickler TS, Traystman RJ. Incomplete global cerebral ischemia alters platelet biology in neonatal and adult sheep. Am J Physiol. 1998;274(4):H1293-H1300. (Pubitemid 28221774)
10. Grau GE, Mackenzie CD, Carr RA, et al. Platelet accumulation in brain microvessels in fatal pediatric cerebral malaria. J Infect Dis. 2003;187(3):461-466.
11. Marquardt L, Ruf A, Mansmann U, et al. Course of platelet activation markers after ischemic stroke. Stroke. 2002;33(11):2570-2574. (Pubitemid 35266425)
12. Karakantza M, Maniatis A, Metallinos CI, Papapetropoulos T, Paschalis C. In vivo platelet activation in ischemic stroke patients. Stroke. 2003;34(10):e174-e175.
13. Sheremata WA, Jy W, Horstman LL, Ahn YS, Alexander JS, Minagar A. Evidence of platelet activation in multiple sclerosis. J Neuroinflammation. 2008;5:27.
14. Love S, Barber R. Expression of P-selectin and intercellular adhesion molecule-1 in human brain after focal infarction or cardiac arrest. Neuropathol Appl Neurobiol. 2001;27(6):465-473. (Pubitemid 34264262)
15. D'Erasmo E, Celi FS, Acca M, Mazzuoli G. Relationship between platelet and white blood cell counts during the early phase of cerebral infarction. Stroke. 1991;22(2):283.
16. Kleinschnitz C, Pozgajova M, Pham M, Bendszus M, Nieswandt B, Stoll G. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding. Circulation. 2007;115(17):2323-2330. (Pubitemid 46685900)
17. Sun G, Chang WL, Li J, Berney SM, Kimpel D, van der Heyde HC. Inhibition of platelet adherence to brain microvasculature protects against severe Plasmodium berghei malaria. Infect Immun. 2003;71(11):6553-6561. (Pubitemid 37337715)
18. Massberg S, Schurzinger K, Lorenz M, et al. Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation. 2005;112(8):1180-1188. (Pubitemid 41216125)
19. Levi M, van der PT, Buller HR. Bidirectional relation between inflammation and coagulation. Circulation. 2004;109(22):2698-2704.
20. Henn V, Slupsky JR, Grafe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature. 1998;391(6667):591-594. (Pubitemid 28157601)
21. Kaplanski G, Porat R, Aiura K, Erban JK, Gelfand JA, Dinarello CA. Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event. Blood. 1993;81(10):2492-2495. (Pubitemid 23147549)
22. Gawaz M, Neumann FJ, Dickfeld T, et al. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation. 1998;98(12):1164-1171. (Pubitemid 28436165)
23. Gawaz M, Brand K, Dickfeld T, et al. Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism: implications for atherogenesis. Atherosclerosis. 2000;148(1):75-85.
24. Hawrylowicz CM, Santoro SA, Platt FM, Unanue ER. Activated platelets express IL-1 activity. J Immunol. 1989;143(12):4015-4018.
25. Diacovo TG, Roth SJ, Buccola JM, Bainton DF, Springer TA. Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18. Blood. 1996;88(1):146-157.
26. Zwaginga JJ, Torres HI, Lammers J, Sixma JJ, Koenderman L, Kuijper PH. Minimal platelet deposition and activation in models of injured vessel wall ensure optimal neutrophil adhesion under flow conditions. Arterioscler Thromb Vasc Biol. 1999;19(6):1549-1554. (Pubitemid 29263027)
27. Boutin H, LeFeuvre RA, Horai R, Asano M, Iwakura Y, Rothwell NJ. Role of IL-1alpha and IL-1beta in ischemic brain damage. J Neurosci. 2001;21(15):5528-5534. (Pubitemid 32692151)
28. McColl BW, Rothwell NJ, Allan SM. Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms. J Neurosci. 2007;27(16):4403-4412.
29. Song L, Pachter JS. Culture of murine brain microvascular endothelial cells that maintain expression and cytoskeletal association of tight junction-associated proteins. In Vitro Cell Dev Biol Anim. 2003;39(7):313-320. (Pubitemid 38200254)
30. Régina A, Romero IA, Greenwood J, et al. Dexamethasone regulation of P-glycoprotein activity in an immortalized rat brain endothelial cell line, GPNT. J Neurochem. 1999;73(5):1954-1963. (Pubitemid 29491808)
31. Zola H, Flego L, Wong YT, Macardle PJ, Kenney JS. Direct demonstration of membrane IL-1 alpha on the surface of circulating B lymphocytes and monocytes. J Immunol. 1993;150(5):1755-1762. (Pubitemid 23129651)
32. Niki Y, Yamada H, Kikuchi T, et al. Membrane-associated IL-1 contributes to chronic synovitis and cartilage destruction in human IL-1 alpha transgenic mice. J Immunol. 2004;172(1):577-584. (Pubitemid 38020515)
33. Luheshi NM, Rothwell NJ, Brough D. The dynamics and mechanisms of interleukin-1alpha and beta nuclear import. Traffic. 2009;10(1):16-25.
34. Clark SR, McMahon CJ, Gueorguieva I, et al. Interleukin-1 receptor antagonist penetrates human brain at experimentally therapeutic concentrations. J Cereb Blood Flow Metab. 2008;28(2):387-394. (Pubitemid 351161294)
35. Lazovic J, Basu A, Lin HW, et al. Neuroinflammation and both cytotoxic and vasogenic edema are reduced in interleukin-1 type 1 receptor-deficient mice conferring neuroprotection. Stroke. 2005;36(10):2226-2231. (Pubitemid 41429251)
36. Relton JK, Rothwell NJ. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull. 1992;29(2):243-246.
37. Allan SM, Tyrrell PJ, Rothwell NJ. Interleukin-1 and neuronal injury. Nat Rev Immunol. 2005;5(8):629-640.
38. Ching S, Zhang H, Belevych N, et al. Endothelial-specific knockdown of interleukin-1 (IL-1) type 1 receptor differentially alters CNS responses to IL-1 depending on its route of administration. J Neurosci. 2007;27(39):10476-10486. (Pubitemid 47502007)
39. Ishikawa M, Vowinkel T, Stokes KY, et al. CD40/CD40 ligand signaling in mouse cerebral microvasculature after focal ischemia/reperfusion. Circulation. 2005;111(13):1690-1696. (Pubitemid 40525171)
40. Zhang ZG, Zhang L, Tsang W, et al. Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion. Brain Res. 2001;912(2):181-194. (Pubitemid 32800673)
41. Lindemann S, Tolley ND, Dixon DA, et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol. 2001;154(3):485-490. (Pubitemid 34286155)
42. Loppnow H, Bil R, Hirt S, et al. Platelet-derived interleukin-1 induces cytokine production, but not proliferation of human vascular smooth muscle cells. Blood. 1998;91(1):134-141. (Pubitemid 28018737)
43. Badimon L, Vilahur G. Platelets, arterial thrombosis and cerebral ischemia. Cerebrovasc Dis. 2007;24[suppl 1]:30-39. (Pubitemid 350035851)
44. Carvalho-Tavares J, Hickey MJ, Hutchison J, Michaud J, Sutcliffe IT, Kubes P. A role for platelets and endothelial selectins in tumor necrosis factor-alpha-induced leukocyte recruitment in the brain microvasculature. Circ Res. 2000;87(12):1141-1148.
45. Danese S, de la Motte C, Sturm A, et al. Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology. 2003;124(5):1249-1264. (Pubitemid 36531801)
46. Garlichs CD, Kozina S, Fateh-Moghadam S, et al. Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia. Stroke. 2003;34(6):1412-1418. (Pubitemid 36693508)
47. Hess DC, Thompson Y, Sprinkle A, Carroll J, Smith J. E-selectin expression on human brain microvascular endothelial cells. Neurosci Lett. 1996;213(1):37-40. (Pubitemid 26249146)
48. Man S, Ubogu EE, Williams KA, Tucky B, Callahan MK, Ransohoff RM. Human brain microvascular endothelial cells and umbilical vein endothelial cells differentially facilitate leukocyte recruitment and use chemokines for T cell migration. Clin Dev Immunol. 2008;2008:384982. (Pubitemid 351441836)
49. Kallmann BA, Wagner S, Hummel V, et al. Characteristic gene expression profile of primary human cerebral endothelial cells. FASEB J. 2002;16(6):589-591.